Small molecule · Inhibitor of HCV NS5B polymerase · developed by Gilead Sciences
Sofosbuvir is a nucleotide prodrug that is converted intracellularly to its active triphosphate form, which inhibits the hepatitis C virus NS5B RNA-dependent RNA polymerase and thereby blocks viral replication. It is used in combination antiviral regimens for chronic hepatitis C virus infection.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Dec 26, 2024). Read the full label for the exact wording, limitations and safety information.
Hepatitis B Virus (HBV)HEPATITIS C (HCV)HIV - Human Immunodeficiency Virus
Updated Oct 18, 2026.